ArticleFrontiers in oncology2024
Asymptotic analysis of mathematical model describing a new treatment of breast cancer using AZD9496 and palbociclib.
Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cancer is a collective name for a group of diseases consisting of dozens of different types of malignant tumors, characterized by rapid and uncontrolled proliferation of cells in the body. Cancer can start almost anywhere in the human body such as the breast, prostate, colorectal, brain, bones, lungs, bladder etc. The main differences between the different types of cancer are related to the organ in which the tumor develops and the type of cells that compose the tumor. Method: This paper focused on the breast cancer. Breast cancer is a malignant tumor that originates in the breast tissue. It is the most common malignant tumor in women. There are several types of breast cancer, but in all types early diagnosis and treatment is crucial. In this study, the treatment of breast cancer involving a combination of two drugs was investigated: the oral estrogen receptor inhibitor AZD9496 and the CDK4/6 protein inhibitor Palbociclib. The mathematical model that described the interaction between the cancer cells, the treatment, and the immune system cells includes a system of nonlinear ordinary differential equations of the firs order. In general, dynamic variables of a given system change each at a different rate. And it is not possible to know from the mathematical model which variable is fast and which is slow. Therefore, in order to reveal the hierarchy of the system of equations ,a numerical algorithm called the singularly perturbed vector field (SPVF) was applied. This algorithm transform the mathematical model to a new coordinate system in which the rate of change of each dynamic variable of the system can be known. Results and Discussion: After writing the mathematical model in new coordinates, the equilibrium point was obtained analytically. The stability of the equilibrium points is investigated, which is essential from a practical perspective. Investigating the stability of the equilibrium points allows determination of when the tumor does not continue to develop and thereby allows adjustment of treatment continuation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.